|
|||||
|
|
Efficacy and safety of gadobutrol‐enhanced MRA of the renal arteries: Results from GRAMS (Gadobutrol‐enhanced renal artery MRA study), a prospective,intraindividual multicenter phase 3 blinded study |
|
| Authors: | Kelly E. Fabrega‐Foster MD MA Sheela Agarwal MD MBA Neda Rastegar MD Daniel Haverstock MS Jacob M. Agris MD PhD Ihab R. Kamel MD PhD |
| Affiliation: | 1. Johns Hopkins Hospital, Department of Radiology, Baltimore, Maryland, USA;2. US Medical Affairs, Bayer HealthCare, Whippany, New Jersey, USA;3. Department of Radiology Rutgers, The State University of New Jersey, Newark, NJ;4. Pharmaceutical Division, Bayer HealthCare, Whippany, New Jersey, USA;5. Director of Global Medical and Clinical Affairs, Bayer HealthCare, Whippany, New Jersey, USA |
| Abstract: | |
| Keywords: | renal artery stenosis contrast‐enhanced MRA time‐of‐flight MRA gadobutrol |